BPC-157

Star2

DB11882InvestigationalSmall molecule

Bepecin is under investigation in clinical trial NCT02637284 (PCO-02 - Safety and Pharmacokinetics Trial).

Formula / weight: C₆₂H₉₈N₁₆O₂₂ · 1419.556 g/mol (avg)
Also known as: Bepecin
Code names: PL-10 · PL-14736 · PLD-116

Resolves to

Compound

UNII8ED8NXK95PCAS137525-51-0PubChem9941957

Structure

InChIKeyHEEWEZGQMLZMFE-RKGINYAYSA-NSMILES

CC(C)C[C@H](NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)[C@H](CCC(O)=O)NC(=O)CN)C(=O)N[C@@H](C(C)C)C(O)=O

Targets

P22303ACHE

What you can answer from here — as of September 05, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

2Clinical trialsPhase, status and sponsor resolved per trial

1+ReferenceStructured and connected to the statements they support

Which drugs share a target with BPC-157, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account